San Mateo, CA, United States of America

David Elgart

This inventor holds 20 USPTO granted patents and 17 published patent applications and 4 EPO patents, primarily in Enzyme Engineering. Top assignee: Codexis, Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Elgart. Retrieved from https://idiyas.com/inventor/david-elgart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 80.0

 

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Engineered Ligases
DNA Polymerase Variants
Penicillin-G Acylases
Tyrosine Ammonia Lyase
Polynucleotides
Cellobiohydrolase Variants
Fungal Xylanases
GH61 Glycoside Hydrolase
20 patents (USPTO):Explore Patents

Title: Innovations by David Elgart in Genetic Engineering

Introduction

David Elgart, based in San Mateo, CA, is a prominent inventor in the field of genetic engineering, holding a remarkable total of 19 patents. His work primarily focuses on engineered DNA polymerases and penicillin G acylases, contributing significantly to advancements in biotechnology.

Latest Patents

Among David Elgart's latest inventions are the engineered DNA polymerase variants, which relate to engineered DNA polymerase polypeptides and their corresponding polynucleotides. These innovations provide methods for utilizing the engineered DNA polymerase for various diagnostic and functional applications. Additionally, he has developed engineered penicillin G acylase (PGA) enzymes, including compositions and methods that leverage these enzymes for enhanced biotechnological applications.

Career Highlights

David is currently employed at Codexis, Inc., a company that specializes in enzyme optimization and biotechnology. His role involves leading research and development initiatives, paving the way for innovative solutions in enzyme-related biotechnology. His extensive patent portfolio reflects his commitment to advancing the field of genetic engineering.

Collaborations

Throughout his career, David has collaborated with notable professionals, including his coworkers Vesna Mitchell and Xiyun Zhang. Their teamwork has further fostered innovation within their projects and contributed to the successful development of their patents.

Conclusion

David Elgart stands out as a pivotal figure in genetic engineering, with a robust patent portfolio that showcases his innovative contributions to biotechnology. His work at Codexis, Inc. continues to influence the industry, setting new precedents for future inventions in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…